Efficacy, Safety and Tolerability of PF-06687234 as Add-on Therapy to Infliximab in Active UC Subjects Not in Remission.

Concord Repatriation General Hospital, Concord

The Royal Melbourne Hospital, Parkville

St. Vincent's Hospital, Melbourne, Fitzroy

Eastern Health-Box Hill Hospital, Box Hill

CHC Montlegia, Liège

St John Of God Health Care Inc. Trading as St. John of God Subiaco Hospital, Subiaco

Fiona Stanley Hospital, Murdoch

"CHC Dr Dragisa Misovic-Dedinje", Belgrade

Clinical Hospital Center Zvezdara - Clinic for Gastroenterology and Hepatology, Belgrade

King Abdullah International Medical Research Center, Riyadh

King Khalid University Hospital, Riyadh

The Catholic University of Korea, St. Vincent's Hospital, Gyeonggi-do

ASST Rhodense - Ospedale di Circolo di Rho, Rho

Chevy Chase Endoscopy Center, Chevy Chase

MGG Group Co., Inc., Chevy Chase Clinical Research, Chevy Chase

King Abdulaziz University Hospital, Jeddah

Universitaetsklinikum Schleswig-Holstein Campus Kiel, Kiel

Emory Investigational Drug Services, Atlanta

Emory University Hospital, Atlanta

Emory University School of Medicine, Atlanta

The Emory Clinic, Atlanta

Mersin Universitesi Tip Fakultesi Hastanesi, Mersin

Azienda Ospedaliera di Padova, Padua

Dothan Surgery Center, Dothan

Gut PC, dba Digestive Health Specialists of the Southeast, Dothan

Eastside Endoscopy Center, Saint Clair Shores

Eastside Endoscopy Center, Macomb

Clinical Research Institute of Michigan, LLC, Chesterfield

Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinical Research Center, Wyoming

East Valley Endoscopy, Grand Rapids

Allegiance Research Specialists, Wauwatosa

The Chaim Sheba Medical Center, Ramat Gan

Fondazione Policlinico Universitario A. Gemelli IRCCS, Roma

Kangbuk Samsung Hospital, Seoul